glp-1 thyroid cancer receptor agonist use for more than 1 year may increase risk Does GLP 1 drug affect

In three nested casecontrol studies from England and Wales, involving 440,089 patients with T2DM and without ASCVD treated with non-insulin glucose-lowering medication, combined SGLT2i and GLP-1RA therapy used for primary prevention was associated with 30% lower odds of MACE (defined as myocardial infarction/acute coronary syndrome, stroke/transient ischemic attack, and/or cardiovascular death) compared with other combination regimens (OR, 0.70

For those using semaglutide to control diabetes, insurance often provides some coverage, though co-pays and out-of-pocket expenses can still add up, depending on the specific insurance plan

T., Raatz, S., Bomberg, E

* ADDITIONAL DETAILS